Clinical Trial Update: Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility [NA]

View source ↗

Summary

Completed clinical trial evaluating extended preservation and assessment time for donor lungs using the Toronto EVLP System at a dedicated facility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease

Drugs mentioned

• Toronto EVLP System (Toronto Ex Vivo Lung Perfusion System)

Snippet

Sponsor: Lung Bioengineering Inc. | Conditions: Lung Disease | NA | Status: COMPLETED | Results posted: 2020-10-09